Rime Bioinformatics
PrivateLast Round
Series A
Jun 11, 2026
Total Funding Raised
$25.39M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Rime Bioinformatics operates in Healthcare & Life Sciences and is based in Palaiseau. Its latest recorded funding round was a Series A round in June 2026.
Rime Bioinformatics is a biotechnology company that develops bioinformatics software and analytical services to accelerate research into alternatives to antibiotics, specifically focusing on bacteriophage genome annotation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rime Bioinformatics Comparables
Compare Rime Bioinformatics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LatchBio | 86% | |
| Pluto Biosciences | 84% | |
| Rosalind | 83% |
For institutional investors. Book with your work email.
Rime Bioinformatics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 11, 2026 | ||||
| Seed | Jun 7, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Rime Bioinformatics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alumni Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 88% MoM.
- Jun 11, 2026
$22.3M round closed
For institutional investors. Book with your work email.
Rime Bioinformatics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Rime Bioinformatics's valuation, stock price, and market status.
Is Rime Bioinformatics a public or private company?
Rime Bioinformatics is a private company.
What is the current stock price of Rime Bioinformatics?
Rime Bioinformatics is a private company, so its shares have no public market price. Caplight tracks Rime Bioinformatics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rime Bioinformatics worth (valuation)?
Valuation information for Rime Bioinformatics is not publicly available.
Can I buy Rime Bioinformatics stock?
Rime Bioinformatics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rime Bioinformatics's last funding round?
Rime Bioinformatics's most recent funding round was Series A on June 11, 2026.
Who are the main investors in Rime Bioinformatics?
Key investors in Rime Bioinformatics include Alumni Ventures.
Will Rime Bioinformatics IPO soon?
No public IPO plans have been announced for Rime Bioinformatics.
How can I track Rime Bioinformatics secondary market activity?
Caplight tracks bids, offers, and trades in Rime Bioinformatics's shares on secondary markets.